These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 9643583)

  • 1. Statistical analysis of lacZ mutant frequency data from MutaMouse mutagenicity assays.
    Fung KY; Douglas GR; Krewski D
    Mutagenesis; 1998 May; 13(3):249-55. PubMed ID: 9643583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The application of the restriction site mutation assay to compare 1-ethyl-1-nitrosourea-induced mutations between the endogenous p53 gene and the transgenic LacZ gene in MutaMouse testes.
    Song HL; Jenkins GJ; Ashby J; Tinwell H; Parry JM
    Mutagenesis; 2001 Jan; 16(1):59-64. PubMed ID: 11139599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for in vivo non-mutagenicity of the carcinogen hydrazine sulfate in target tissues of lacZ transgenic mice.
    Douglas GR; Gingerich JD; Soper LM
    Carcinogenesis; 1995 Apr; 16(4):801-4. PubMed ID: 7728958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statistical analysis of the lacI transgenic mouse mutagenicity assay.
    Fung KY; Krewski D; Zhu Y; Shephard S; Lutz WK
    Mutat Res; 1997 Mar; 374(1):21-40. PubMed ID: 9067413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of mutagenicity of levofloxacin in lacZ transgenic mice.
    Itoh S; Miura M; Shimada H
    Mutagenesis; 1998 Jan; 13(1):51-5. PubMed ID: 9491394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The development and prevalidation of an in vitro mutagenicity assay based on MutaMouse primary hepatocytes, Part II: Assay performance for the identification of mutagenic chemicals.
    Cox JA; Zwart EP; Luijten M; White PA
    Environ Mol Mutagen; 2019 May; 60(4):348-360. PubMed ID: 30714215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relative activities of methyl methanesulphonate (MMS) as a genotoxin, clastogen and gene mutagen to the liver and bone marrow of MutaMouse mice.
    Tinwell H; Lefevre PA; Ashby J
    Environ Mol Mutagen; 1998; 32(2):163-72. PubMed ID: 9776179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-Nitrosodi-n-propylamine induces organ specific mutagenesis with specific expression times in lacZ transgenic mice.
    Itoh S; Miura M; Itoh T; Miyauchi Y; Suga M; Takahashi Y; Kasahara Y; Yamamura E; Hirono H; Shimada H
    Mutat Res; 1999 Aug; 444(2):309-19. PubMed ID: 10521671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone marrow and liver mutagenesis in lacZ transgenic mice treated with hexavalent chromium.
    Itoh S; Shimada H
    Mutat Res; 1998 Jan; 412(1):63-7. PubMed ID: 9508365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sources of variability in data from a lacI transgenic mouse mutation assay.
    Piegorsch WW; Lockhart AM; Margolin BH; Tindall KR; Gorelick NJ; Short JM; Carr GJ; Thompson ED; Shelby MD
    Environ Mol Mutagen; 1994; 23(1):17-31. PubMed ID: 8125080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutagenicity of ethyl carbamate to lacZ- transgenic mice.
    Williams CV; Fletcher K; Tinwell H; Ashby J
    Mutagenesis; 1998 Mar; 13(2):133-7. PubMed ID: 9568584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue-specific metabolic activation and mutagenicity of 3-nitrobenzanthrone in MutaMouse.
    Chen G; Gingerich J; Soper L; Douglas GR; White PA
    Environ Mol Mutagen; 2008 Oct; 49(8):602-13. PubMed ID: 18613036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Organ distinctive mutagenicity in MutaMouse after short-term exposure to PhIP.
    Lynch AM; Gooderham NJ; Boobis AR
    Mutagenesis; 1996 Sep; 11(5):505-9. PubMed ID: 8921513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A lacZ transgenic mouse assay for the detection of mutations in follicular granulosa cells.
    Yauk CL; Gingerich JD; Soper L; MacMahon A; Foster WG; Douglas GR
    Mutat Res; 2005 Oct; 578(1-2):117-23. PubMed ID: 16039675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Duplex sequencing provides detailed characterization of mutation frequencies and spectra in the bone marrow of MutaMouse males exposed to procarbazine hydrochloride.
    Dodge AE; LeBlanc DPM; Zhou G; Williams A; Meier MJ; Van P; Lo FY; Valentine Iii CC; Salk JJ; Yauk CL; Marchetti F
    Arch Toxicol; 2023 Aug; 97(8):2245-2259. PubMed ID: 37341741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimutagenic structural modification of quinoline assessed by an in vivo mutagenesis assay using lacZ-transgenic mice.
    Miyata Y; Saeki K; Kawazoe Y; Hayashi M; Sofuni T; Suzuki T
    Mutat Res; 1998 May; 414(1-3):165-9. PubMed ID: 9630605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benzo[a]pyrene site of contact mutagenicity in skin of Muta Mouse.
    Dean SW; Coates A; Brooks TM; Burlinson B
    Mutagenesis; 1998 Sep; 13(5):515-8. PubMed ID: 9800197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genotoxicity of 3-nitrobenzanthrone and 3-aminobenzanthrone in MutaMouse and lung epithelial cells derived from MutaMouse.
    Arlt VM; Gingerich J; Schmeiser HH; Phillips DH; Douglas GR; White PA
    Mutagenesis; 2008 Nov; 23(6):483-90. PubMed ID: 18635558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of the effects of diverse mutagens at the lacZ transgene and Dlb-1 locus in vivo.
    Cosentino L; Heddle JA
    Mutagenesis; 1999 Jan; 14(1):113-9. PubMed ID: 10474832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Folate Intake Alters Mutation Frequency and Profiles in a Tissue- and Dose-Specific Manner in MutaMouse Male Mice.
    Diaz G S; LeBlanc DP; Gagné R; Behan NA; Wong A; Marchetti F; MacFarlane AJ
    J Nutr; 2021 Apr; 151(4):800-809. PubMed ID: 33693772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.